NIKKI CLATT: Open Payments
NPI 1568101822 · ASHLAND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $75 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Dexcom, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| ABBVIE INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Organon LLC | 1 | $17 |
Products named: MOUNJARO, REXULTI, NURTEC ODT, Dexcom G6 Transmitter, AIRSUPRA, VRAYLAR, Auvelity, Rybelsus.
Industry payments across MO — which companies pay providers there.
